Month: July 2025

Jul 16 2025

Uncategorized

Hepatitis C Found in Brain Lining Linked to Schizophrenia, Bipolar Disorder – Neuroscience News

by Clinical Editor

No Comments

Hepatitis C Found in Brain Lining Linked to Schizophrenia, Bipolar Disorder  Neuroscience News

Jul 16 2025

Uncategorized

Hepatitis C Found in Brain Lining Linked to Schizophrenia, Bipolar Disorder

by Clinical Editor

No Comments

Researchers have discovered hepatitis C virus (HCV) in the brain lining of individuals with schizophrenia and bipolar disorder, suggesting a possible link between infection and psychiatric symptoms.

Jul 15 2025

Uncategorized

J&J sues over schizophrenia drug generic following patent victory – Life Sciences Intellectual Property Review

by Clinical Editor

No Comments

J&J sues over schizophrenia drug generic following patent victory  Life Sciences Intellectual Property Review

Jul 15 2025

Uncategorized

New research leaves Hopkins scientists wondering if antiviral drugs can treat bipolar, schizophrenia

by Clinical Editor

No Comments

A new medical study out of Johns Hopkins Children’s Center could potentially be a game changer for those suffering certain mental disorders.

Jul 14 2025

Uncategorized

New Consensus Guidelines for Clozapine Drop ANC Monitoring After 2 Years

by Clinical Editor

No Comments

Monitoring absolute neutrophil count levels beyond 2 years of clozapine treatment is no longer necessary, new international guidelines state.

Jul 14 2025

Uncategorized

The Science of Psychosis

by Clinical Editor

No Comments

Contemporary research has brought psychosis out of the dark, transforming our relationship to it from one of fear and rejection to one of hope and recovery.

Jul 13 2025

Uncategorized

A surprising body part might provide key insights into schizophrenia risk

by Clinical Editor

No Comments

A new study published in Nature Mental Health has found that people with a higher genetic risk for schizophrenia tend to have thinner retinas, even if they do not have...

Jul 13 2025

Uncategorized

Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data

by Clinical Editor

No Comments

Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced the submission of a supplemental New Drug Application/sNDA...

Jul 12 2025

Uncategorized

Treatments for Schizophrenia with Accordia Health’s Dr. Evan Chavers and Dr. Shyla Hossain

by Clinical Editor

No Comments

Dr. Evan Chavers and Dr. Shyla Hossain from Accordia Health joined WKRG News 5’s The Doctor is In to discuss schizophrenia and available treatment options.  In the video …

Jul 12 2025

Uncategorized

AZ man’s death on hot pavement was due to negligence, lawsuit claims

by Clinical Editor

No Comments

LaFayette Palmes was found dead on the pavement in July 2024 with a body temperature of almost 110 degrees, according to the suit.